openPR Logo
Press release

Research Offers 10-Year Forecast on Inflammatory Diseases Market

05-26-2017 03:40 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Future Market Insights

Research Offers 10-Year Forecast on Inflammatory Diseases

A new understanding of inflammatory diseases has changed the drug development landscape for several major diseases that are affecting millions of people in the world. Inflammation describes the primary response of the body that eliminates the cause of injury. Periodically, body’s defense mechanism works inappropriately that leads to inflammation. Drug development has focused on treating each disease symptoms separately. The discovery of drugs to treat inflammatory diseases related with immune system is driving the market towards growth. Immune Mediated Inflammatory diseases represent a global threat in terms of quality of life, morbidity and mortality that leads to increasing opportunity to develop new treatments to conquer the inflammatory diseases and increase market share. On the top inflammatory diseases are most common in human beings. Increasing popularity of inflammatory diseases and treatment followed by anti-inflammatory drugs with lesser side effects is driving the global inflammatory diseases market.

Based on type of diseases, global inflammatory diseases market can be segmented into following

Respiratory Diseases


Chronic obstructive pulmonary disease

Heart disease

Multiple Sclerosis


Inflammatory Bowel Disease

Bone disease

Rheumatoid Arthritis



Based on type of drug class, global inflammatory diseases market can be segmented into following

Anti-inflammatory Biologics

Non-steroidal Anti-Inflammatory Drugs



Request Report Sample@

Based on type of distribution channel, global inflammatory diseases market can be segmented into following

Hospital pharmacy

Retail pharmacy

Drug stores

Online pharmacy

On the basis of type of disease global inflammatory diseases market is segmented into respiratory diseases, heart disease, multiple sclerosis, Psoriasis, inflammatory bowel disease, bone disease and others. Respiratory diseases are further classified into asthma and chronic obstructive pulmonary disease, where asthma is a condition in that a person’s airways become swollen, narrow and inflamed to produce extra mucus and chronic obstructive pulmonary disease (COPD) is name for a group of lung conditions that causes due to smoking in adults that leads to breathing difficulties. Heart disease or heart disorders are conditions in that heart stops functioning, there are several types of heart diseases like arrhythmias heart disease, atherosclerotic and cardiomyopathy. Multiple sclerosis is a degenerative disease that attack central nervous system and disrupts the flow of information within the brain. Psoriasis is systemic inflammation that causes red and flaky plaques with joint pain of psoriatic arthritis. Inflammatory bowel disease involves inflammation related with gastro intestinal tract, includes to most common diseases of gastro intestinal tract that are crohn’s disease and ulcerative disease. Bone disease mostly includes rheumatoid arthritis and osteoarthritis.

Moreover, on the basis of drug class used in treatment of inflammatory diseases global inflammatory diseases market is segmented into non-steroidal anti-inflammatory drugs, anti-inflammatory biologics and corticosteroids. Non-steroidal anti-inflammatory drugs bound the production of hormones in the body such as prostaglandins that is responsible for inflammation. Anti-inflammatory biologics are mostly used in treatment of arthritis indications in rheumatoid arthritis and osteoarthritis that is one of the revenue generating segment followed by respiratory diseases like asthma and chronic obstructive pulmonary disease. On the basis of distribution channel global inflammatory disease market is segmented into hospital pharmacy, retail pharmacy, drug stores and online pharmacy.

Request For TOC@

Geographically, global inflammatory market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific and Middle East Africa. North Amrica is dominating in inflammatory diseases market as there is demand for branded medicines over the generic medicines. Rising geriatric population is driving the inflammatory diseases market throughout the globe. Followed by North America, Asia Pacific and Latin America has shown increasing market share in inflammatory diseases.

Some of the major players in global inflammatory diseases market are AstraZeneca, Merck & Co., GlaxoSmithKline, Bristol-Myers Squibb, F-Hoffmann-La-Roche, Eli Lilly and Sanofi. Other emerging competitors like Enlivex Therapeutics Ltd., Gilead Sciences, Immune Pharmaceuticals, Merck, Mitsubishi Tanabe Pharma Corporation, Neovacs, Prometheus Laboratories, Sandoz, and Takeda Pharmaceuticals are developing drug pipeline and launch of new products as key strategies.

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Research Offers 10-Year Forecast on Inflammatory Diseases Market here

News-ID: 553210 • Views: 419

More Releases from Future Market Insights

Rapid Urbanization and Changing Lifestyles Fuel Growth of PS Containers Market, Projected to Exceed US$ 1.7 Billion by 2033
Rapid Urbanization and Changing Lifestyles Fuel Growth of PS Containers Market, …
The net worth of the PS Containers market share is anticipated to increase from US$ 1352.7 million in 2023 to US$ 1747.3 million or more by 2033. From 2023 to 2033, the market is anticipated to grow at a CAGR of 2.6%. The demand for PS containers has increased as a result of rapid urbanization and changing lifestyles, particularly in emerging nations. The highest grade foamed polystyrene, which can be easily
Global Twist Tie Machines Market Set to Reach US$ 16.3 Billion by 2032, Riding Rapid Growth Trend
Global Twist Tie Machines Market Set to Reach US$ 16.3 Billion by 2032, Riding R …
The twist tie machines market is expected to grow at a CAGR of 5.45% from 2022 to 2032. The market is being driven by the increasing demand for twist ties in various end-use industries, such as food and beverage, packaging, and others. Twist ties are used to secure bags, bundles, and other items. They are also used as a decorative element in packaging. The global twist tie machines market is segmented by type,
Online Retailing Boosts Horticulture Film Sales: Convenience and Efficiency Drive Market Expansion
Online Retailing Boosts Horticulture Film Sales: Convenience and Efficiency Driv …
The global horticulture film market is on a significant growth trajectory, with a projected value of US$ 19.55 billion by 2032. In 2022, the market is estimated to be worth US$ 10.89 billion, and it is expected to maintain a strong compound annual growth rate (CAGR) of 6.20% from 2022 to 2032. Despite potential economic challenges in both developed and developing regions, the horticulture film market continues to flourish, driven
North America's Rapid Rise in Multiflex Tubes Market: Innovation and Leakage-Proof Packaging Drive Demand
North America's Rapid Rise in Multiflex Tubes Market: Innovation and Leakage-Pro …
Through 2032, it is anticipated that sales of multiflex tubes will generate an absolute dollar potential of close to US$ 900 million, growing at a CAGR of roughly 6% to 7% from 2022 to 2032. In contrast to the US$ 1 Billion recorded in 2021, the demand for multiflex tubes is predicted to reach a value of US$ 1.9 Billion by the end of 2032. The Multiflex Tubes Market is experiencing significant growth

All 5 Releases

More Releases for Inflammatory

Inflammatory Bowel Disease Market: The Present and Future of Inflammatory Bowel …
Stratagem Market Insights have included the latest addition of a global market research report titled Inflammatory Bowel Disease Market tits expansive repository. The report studies primary and secondary research in order to analyze the data effectively. The market study further draws attention to crucial industry factors such as global clients, potential customers, and sellers, which instigates positive company growth. In order to gauge the turning point of the businesses, significant
Inflammatory Marker Market Size, Share, Development by 2024
LP INFORMATION offers a latest published report on Inflammatory Marker Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the Inflammatory Marker market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular,
Rising incidences of chronic inflammatory and autoimmune diseases has increased …
According to a new report published by, titled, Anti-inflammatory Therapeutics Asia-Pacific Market Research Report, 2014-2020, the Asia-Pacific anti-inflammatory therapeutics market is expected to grow at a CAGR of 8.6% during the period of 2015-2020. The arthritis segment would continue to lead the Asia Pacific anti-inflammatory therapeutics market through 2020. China anti-inflammatory therapeutics market is forecast to grow at the highest CAGR of 13.9% during the forecast period. Get the sample
Digital Landscape: Inflammatory Bowel Disease Market
The Digital Landscape Inflammatory Bowel Disease market report analyzes digital activities undertaken by pharma in support of disease-modifying therapies for mild-to-moderate, and moderate-to-severe Crohn’s disease and ulcerative colitis (UC). Key Highlights - US Patients: AbbVie offers the strongest support for IBD patients in the US, particularly branded, unbranded and mobile app. Janssen was the most active competitor in the branded and social media spaces in 2017. Branded activity also seen from pipeline
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H2 2 …
ReportsWorldwide has announced the addition of a new report title Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H2 2017, provides an overview of the Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (Central Nervous System) pipeline landscape. Chronic inflammatory demyelinating polyneuropathy (CIDP) also called as
Chronic Inflammatory Demyelinating Polyneuropathy (CIPD) Treatment Market
Chronic inflammatory demyelinating polyneuropathy (CIPD) is an autoimmune disorder of the peripheral nervous system characterized by the weakness and impaired sensory function in the arms and legs. This disorder is caused by damage to the myelin sheath, a fatty covering that wraps and protects nerve fibers. The nerves stimulate muscle contraction and transmit sensory information to the brain through electrical impulses. Myelin acts as an insulation and allows efficient flow